Endocrine Abstracts

Contents

• 9th International Adrenal Cancer Symposium 2024
• • Abstracts
  • • Cross-study reconciliation of SF-1 regulatory targets in adrenocortical carcinoma through in silico analysis

      ea0107001
    • Evaluating the response of immunotherapy in metastatic adrenocortical carcinoma - a single institution retrospective review

      ea0107002
    • Clinical presentation, management, and outcomes of patients with small (≤ 4 cm) adrenocortical carcinoma: single-center retrospective cohort study

      ea0107003
    • Circulating cell-free DNA for adrenal masses discrimination: a pilot study

      ea0107004
    • Outcome of combination chemotherapy for metastatic adrenocortical carcinoma

      ea0107005
    • Phase 2 study of monotherapy with pembrolizumab for advanced adrenocortical carcinoma

      ea0107006
    • Combination therapy of multi-targeted tyrosine kinase inhibitors and immune checkpoint inhibitors for advanced adrenocortical carcinoma

      ea0107007
    • Clinical and genetic characteristics of patients with adrenocortical carcinoma and lynch syndrome

      ea0107008
    • Characterizing the biology of ACC by longitudinal dual-PET imaging and multi-omics analyses

      ea0107009
    • Dual inhibition of PLK1 and multiple CDKs: a novel approach for the treatment of adrenocortical carcinomas

      ea0107010
    • In vivo CRISPR screening identifies tada2b as a key epigenetic regulator of immune response in adrenocortical carcinoma

      ea0107011
    • PCDHGC3 hypermethylation as a diagnostic and prognostic biomarker in adrenocortical carcinomas

      ea0107012
    • Discovery and characterization of OR-449, a potent antagonist to steroidogenic factor-1 (SF-1) and clinical candidate for treatment of ACC

      ea0107013
    • Silent adrenal neoplasm masquerading as adrenocortical carcinoma in a patient with neurofibromatosis type 1

      ea0107014
    • Bone metastasis model for the interrogation of ACC progression and therapeutic response: lessons learned from genitourinary cancers

      ea0107015
    • Chloroquine inhibits adrenocortical carcinoma cell survival independent of its effects on autophagy

      ea0107016
    • Practice patterns, characteristics, and clinical outcomes for patients with ACC referred to a tertiary academic medical center

      ea0107017
    • Bilateral adrenal carcinoma: a rare case report

      ea0107018